According to a report from The Guardian, Ms. Cafferkey was initially admitted to Queen Elizabeth University Hospital in Glasglow but has since been transferred. “We can confirm that Pauline Cafferkey is being transferred to the Royal Free hospital due to a late complication from her previous infection by the Ebola virus. She will now be treated by the hospital’s infectious diseases team under nationally agreed guidelines,” a spokesman for London-based Royal Free Hospital told The Guardian.
Ms. Cafferkey became infected in Sierra Leone in December 2014. She spent a month isolated at Royal Free. She was released after being treated with an Ebola survivor’s plasma and an experimental antiviral drug. In October of 2015, she became ill and was readmitted to the Royal Free with meningitis, which was the result of complications spurred by the Ebola virus.
This past July, the CDC announced a new vaccine was very effective and could assist in the prevention of Ebola.
More articles on infection control:
Can researchers foil Zika-spreading mosquitoes by using bacteria as a Trojan horse?
Researchers reveal how flu virus hides undetected from the immune system
28 largest US public health departments urge Congress to approve Zika funding
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
